SOURCE: Issues Investment Alert On (NASDAQ:LGND), (NASDAQ:BMTI, (NASDAQ:GENE), (NASDAQ:HNSN), (NASDAQ:MRGE) Is announcing Investment Highlights on Ligand Pharmaceuticals (NASDAQ:LGND), BioMimetic Therapeutics (NASDAQ:BMTI), Genetic Technologies (NASDAQ:GENE), Hansen Medical (NASDAQ:HNSN), Merge Healthcare Inc.(NASDAQ:MRGE)

POMPANO BEACH, FL, United States, via ETELIGIS INC., 11/19/2012 - - Ligand Pharmaceuticals Inc.(NASDAQ: LGND) stock gained 13.08% to $18.85. The company said the U.S. Food and Drug Administration has granted its partner, GlaxoSmithKline PLC, approval for Promacta--its low blood platelet count treatment--for patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy. Promacta is the brand name that eltrombopag, a thrombopoietin receptor agonist, is marketed under in the U.S.


Will LGND Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here


BioMimetic Therapeutics, Inc.(NASDAQ: BMTI) shares soared 70.84% to $7.09 in the morning hour after Wright Medical Group agreed to acquire BioMimetic Therapeutics for about $190 million in cash and stock as it looks to expand its extremities business. Wright agreed to pay $1.50 in cash and 0.2482 of a Wright share for each BioMimetic share.


How Should Investors Trade BMTI After The Recent Momentum, Find Out Here


Genetic Technologies Limited (ADR)(NASDAQ: GENE) shares climbed 5.20% to $2.79 in the early hour. The company, last month, announced that it has issued 10,200,000 fully paid ordinary shares at an issue price of AUD 0.045 per share as a result of the exercise of options. The 52 week trading range for the company is $2.29 - $6.20. The shares of the company fell 26% in the last one year.


Get Free Special Trend Analysis On GENE Here


Hansen Medical, Inc.(NASDAQ: HNSN) shares climbed 5.44% to $2.11. The company said Intuitive Surgical bought 5.3 million shares of Hansen stock for $10 million, and agreed to pay $20 million to get an extended license to patents owned by Hansen. Intuitive bought the stock for $1.89 per share. The deal will give Intuitive patents relating to "certain non-vascular approaches," or procedures that don't go through blood vessels.


Get Free Special Trend Analysis On HNSN Here


Merge Healthcare Inc.(NASDAQ:MRGE) shares gained 3.73% and closed at $2.78. The company will unveil a national mobile and internet platform for consumers and demonstrate how enterprise imaging solutions support achieving Meaningful Use objectives at the Radiological Society of North America (RSNA) in booth #4845. The company is showcasing a new mobile and Internet platform for consumers to select a radiologist, schedule an appointment and receive results electronically.


Get Free Special Trend Analysis On MRGE Here


About has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.


Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.



The assembled information disseminated by is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. does expect that investors will buy and sell securities based on information assembled and presented in PLEASE always do your own due diligence, and consult your financial advisor.







Views by Registered Users: 0
Views by Non-Registered Users: 46
Total Like Count: 0
Total Dislike Count: 0
No Comment History

Add Comment